Optolane Technologies
Latest round
- Series C
Last raised
- Dec 2019
Total raised
- $34M
Investors
- 11
About Optolane Technologies
Based in Seongnam, South Korea, and founded in 2012, Optolane Technologies Inc. offers digital diagnostic kits utilizing image sensor technology to test for coronavirus, oncology, and other respiratory illnesses in patients. Additionally, the company provides a software platform that allows users to access and view test results. The company was founded by its CEO, Doyoung Lee. In July 2023, Optolane Technologies Inc. The company specializes in developing a diagnostic device that offers molecular and immunoassay alternatives for point-of-care testing (POCT). Its semiconductor-integrated In-Vitro Diagnostic device focuses on real-time PCR and Digital PCR by combining optical and thermal control systems. This integration enables individuals to receive disease diagnosis. The company offers a diagnostic platform for disease diagnosis and preventive home healthcare markets.
Who invested in Optolane Technologies
11 investors across 4 rounds
See all investors in Optolane Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Optolane Technologies
Who invested in Optolane Technologies?
Optolane Technologies has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Optolane Technologies raised?
Optolane Technologies has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Optolane Technologies last raise money?
Optolane Technologies's most recent round on record is a Series C, in Dec 2019.
What does Optolane Technologies do?
Based in Seongnam, South Korea, and founded in 2012, Optolane Technologies Inc.
Where is Optolane Technologies headquartered?
Optolane Technologies is headquartered in Seongnam, South Korea.
Which VCs invest in companies like Optolane Technologies?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Optolane Technologies's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like Optolane Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.